Newly Activated Studies

These studies have recently activated.

More information can be found on CTSU.

A222301: High-Dose Prophylactic Gabapentin (HOPE) to Prevent Opioid Use for Oral Mucositis Pain During Head and Neck Chemoradiotherapy: A Phase III Clinical Trial
A032303: GAIN-BCG: Gemcitabine Alternating with INtravesical BCG Randomized Against BCG Alone for Patients with Recurrent High Grade Non-Muscle Invasive Bladder Cancer
NRG-GI011: A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)
NRG-CC015: Harnessing E-Mindfulness Approaches for Living After Breast Cancer --- HEAL-ABC
EA4231: A Phase 2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed or Refractory CD10-Negative Diffuse-Large B-Cell Lymphoma (DLBCL) and High-Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements (HGBCL-DH-BCL2)

Research Base Meetings

SWOG Fall Meeting: September 18-20, 2025 - Chicago, IL

URCC Fall Meeting: September 25-28, 2025 - Niagara Falls, NY

Wake Forest Fall Meeting: October 6-8, 2025 - Asheville, NC

ECOG-ACRIN Fall Meeting: October 22-24, 2025- Philadelphia

Accruals, Biospecimens, & Special Entries

Under-Represented Populations

CCDR Corner

All About AYAs

Cancer Survivor's Day

Pictured above (left to right): Kamara Mertz-Rivera, Amy Curtis MD, Chad Dingman

On June 1st, staff at SMC celebrated National Cancer Survivors Day at the Annual Survivors Day celebration hosted by Gibbs Cancer Center. This day honors survivors, supports those still in treatment, and recognizes the families, friends, and healthcare professionals who walk alongside them.